Talk:Fenofibrate

message: I'm taking Tricor 145mg and it keeps me from getting any gout attacks. I was regulating my gout with diet and Allopurinol 100mg and attacks with Indomethacin50mg. After starting with Tricor I stopped the other medications and as long as I take the Tricor I don't get any signs of gout.  —Preceding unsigned comment added by D1hamby (talk • contribs) 11:53, 20 June 2008 (UTC)
thread_title: Untitled

message: most of the studies listed in this article point to the positive effects of TriCor.   What about the 2003 study that showed that TriCor had NO effect for diabetics, and the new 2010 (funded by the National Heart, Lung and Blood Institute) in which 5,500 patients with diabetes showed no statistical differences in rates of heart attack, stroke, or death as compared with a placebo (the "Accord" trial)?  —Preceding unsigned comment added by 74.179.113.6 (talk) 19:34, 2 April 2010 (UTC)
thread_title:  other studies 

message: I read that fenofibrate is used in pharmacological studies as an "selective amyloid raising agent". Is that an important use for fenofibrate? Crampino (talk) 17:52, 3 December 2010 (UTC)
thread_title:  selective amyloid raising agent 

message: "Trilipix (fenofibric acid): Drug Safety Communication - Label Change
AUDIENCE: Family Practice, Cardiology, Pharmacy
ISSUE: FDA notified healthcare professionals the cholesterol-lowering medicine Trilipix (fenofibric acid) may not lower a patient's risk of having a heart attack or stroke. FDA reviewed the data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid trial. The ACCORD Lipid trial found no significant difference in the risk of experiencing a major adverse cardiac event between the group treated with fenofibrate plus simvastatin compared with simvastatin alone.
Information from the trial has been added to the Important Limitations of Use and Warnings and Precautions sections of the Trilipix physician label and to the patient Medication Guide.
BACKGROUND: Trilipix (fenofibric acid) was approved by FDA in 2008 to treat cholesterol in the blood by lowering the total amount of triglycerides and low-density lipoprotein (LDL) cholesterol, and increasing the high-density lipoprotein (HDL) cholesterol.
RECOMMENDATION: Fenofibrate at a dose equivalent to 135 mg of Trilipix was not shown to reduce coronary heart disease morbidity and mortality in patients in two large randomized controlled trials of patients with type 2 diabetes mellitus; healthcare professionals should consider the benefits and risks of Trilipix when deciding to prescribe the drug to patients, and counsel patients about those benefits and risks." 
If anyone wishes to make a reference to that announcement in the article, it's at http://links.govdelivery.com/track?type=click&enid=ZWFzPTEmbWFpbGluZ2lkPTIwMTExMTA5LjM4NDk5NjEmbWVzc2FnZWlkPU1EQi1QUkQtQlVMLTIwMTExMTA5LjM4NDk5NjEmZGF0YWJhc2VpZD0xMDAxJnNlcmlhbD0xNjc4MDA3OCZlbWFpbGlkPXN0ZXBoZW4ucC52aWxsYW5vQGdtYWlsLmNvbSZ1c2VyaWQ9c3RlcGhlbi5wLnZpbGxhbm9AZ21haWwuY29tJmZsPSZleHRyYT1NdWx0aXZhcmlhdGVJZD0mJiY=&&&102&&&http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm279185.htm 
Wzrd1 (talk) 15:51, 9 November 2011 (UTC)
thread_title:  FDA MedWatch announcement 9-Nov-2011 

message: The unquoted sentence "In particular, ACCORD-Lipid trial, in our view, supports the addition of fenofibrate to statin therapy" is a plagiarism from http://www.ncbi.nlm.nih.gov/pubmed/21102326 - Robert Badgett 14:14, 10 November 2011 (UTC)
thread_title: Plagiarism

message: Please accept the edits to this page (February 14, 2013). My name is Scott Stoffel, and I work at Abbott Laboratories in Corporate Public Affairs, and the edits I am providing are all factual, based upon review of the page with Abbott Laboratories scientists who have expertise in this area. If you have questions, please do not hesitate to access my contact information, found here: http://abbott.com/news-media/contacts.htm  — Preceding unsigned comment added by ScottStoffelAbbott (talk • contribs) 18:31, 14 February 2013 (UTC)
thread_title: Abbott Laboratories 

message: Is it a trade name for this drug? It is not mentioned within the article. 86.179.191.90 (talk) 01:23, 8 February 2015 (UTC)
replies: text: Not a trade name, but the first common name by which fenofibrate was known (much as "acetaminophen" and "paracetamol" refer to the same drug). The article is a bit of a mess, but I suppose this warrants mention in a brief "History" section. Fvasconcellos (t·c) 02:02, 8 February 2015 (UTC)
thread_title:  Why does "Procetofen" redirect here? 

message: Fenofibrate is the isopropyl ester of Fenofibric acid. but Fenofibric acid redirects to here.  — Preceding unsigned comment added by 79.74.30.197 (talk) 18:22, 3 June 2016 (UTC)
thread_title: Fenofibric acid